Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants
- 18 July 2020
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (9) , 2085-2093
Abstract
Transient abnormal myelopoiesis (TAM) raises the risk for acute myeloid leukemia of Down syndrome (DS) (ML‐DS), and both are related to GATA1 pathogenic variants. Here, we analyzed which findings on complete blood count (CBC) are associated with TAM in a cohort of neonates with DS screened for GATA1 pathogenic variants. The CBCs were compared among 70 newborns with DS, including 16 patients (22.9%) with TAM (cases), and 54 patients (77.1%) without TAM (controls). TAM was defined as peripheral circulating blasts (PCBs) ≥ 1%. PCR and direct sequencing were used to screen DNA samples from peripheral blood for GATA1 exon 2 mutations. Multivariate logistic regression analyses determined that the mean count of lymphocytes was significantly higher in DS infants with TAM (p = .035) and that lymphocytosis confers a risk for TAM (adjusted odds ratio = 7.23, 95% confidence intervals: 2.02–25.92). Pathogenic variants of GATA1 were identified in 2 of 70 analyzed DS neonates (2.9%), of which one had ML‐DS and another had an asymptomatic TAM. Among those DS infants with TAM, the GATA1 pathogenic variant detection was 12.5%. Our results indicated that lymphocytosis is associated with TAM in neonates with DS. However, since not all infants with an abnormal CBC had TAM, and not all infants with TAM had GATA1 pathogenic variants, we emphasize that only the search for GATA1 pathogenic variants allows the proper identification of the subgroup of DS infants with a real increasing in risk for ML‐DS.Keywords
This publication has 25 references indexed in Scilit:
- Management of Neonates With Suspected or Proven Early-Onset Bacterial SepsisPediatrics, 2012
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Blood, 2011
- Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemiaBlood, 2011
- Distinctive hematological abnormalities in East Asian neonates and children with down syndromeInternational Journal of Laboratory Hematology, 2011
- Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemiaBlood, 2010
- Incidence and clinical implications of GATA1 mutations in newborns with Down syndromeBlood, 2007
- Hematological abnormalities during the first week of life among neonates with Down syndrome: Data from a multihospital healthcare systemAmerican Journal of Medical Genetics Part A, 2006
- Transient Leukemia (Transient Myeloproliferative Disorder, Transient Abnormal Myelopoiesis) of Down SyndromeAdvances in Anatomic Pathology, 2006
- Natural history of GATA1 mutations in Down syndromeBlood, 2004
- Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21Blood, 2003